Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)

v3.25.1
Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Product Information [Line Items]    
Total revenue, net $ 6,770 $ 34,984
Diagnostic services    
Product Information [Line Items]    
Total revenue, net 0 24,849
Retail and others    
Product Information [Line Items]    
Total revenue, net 1,492 2,378
Genomic products and services    
Product Information [Line Items]    
Total revenue, net $ 5,278 $ 7,757